New study aims to reduce infections after esophagus cancer surgery
NCT ID NCT06911658
First seen Jun 25, 2026 · Last updated Sep 15, 2026 · Updated 3 times
Summary
This study reviews medical records of 350 adults who had surgery for esophageal cancer in France between 2017 and 2024. Researchers want to understand how often infections happen after surgery, what causes them, and how they affect recovery. The goal is to find ways to prevent these infections and improve patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify factors that increase infection risk after esophageal cancer surgery, leading to better prevention and care.
- What could go wrong
- This is an observational study that looks back at past records, so it cannot prove cause and effect. Results may not apply to all hospitals or patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,029 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Sep 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Hospitalized patients in intensive care unity.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients over 18 years of age * Underwent esophagectomy for cancer between January 1, 2017, and December 31, 2024 * Scheduled admission to intensive care for postoperative monitoring Exclusion Criteria: * Opposition to the use of data
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Esophageal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Saint-Louis - APHP
Paris, 75010, France
-
Saint Louis Hospital
Paris, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood proteins may predict who beats esophageal cancer with chemoradiation
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers
- A standard IV fluid dose may reveal who is at risk after bowel surgery
- Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
- Can a direct hit to tumors make immunotherapy work better?
- New antibody aims to preserve immune checkpoint while fighting cancer